Watanabe Ami

Research theme for competitive and other funds (4)：

2020 - 2023 膵β細胞のインスリン分泌能成熟過程におけるTSPANの役割解明
2016 - 2019 Differentiation of functional islets from human iPS cells and hiPS-endocrine progenitor cells in vitro.
2015 - 2018 Development and finding the mechanism of pancreatic beta cell differentiation from hiPS cells through Single cell analysis
2014 - 2017 High efficiency differentiation of functional islets from human iPS cells and hiPS-endocrine progenitor cells in vitro.

Papers (3)：

Ami Watanabe, Anna Tanaka, Chizuko Koga, Masahito Matsumoto, Yasushi Okazaki, Tatsuya Kin, Atsushi Miyajima. CD82 is a marker to isolate beta cell precursors from human iPS cells and plays a role for the maturation of beta cells. SCIENTIFIC REPORTS. 2021. 11. 1
Anna Tanaka, Ami Watanabe, Yasuhiro Nakano, Masahito Matsumoto, Yasushi Okazaki, Atsushi Miyajima. Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells. Genes to cells : devoted to molecular & cellular mechanisms. 2020. 25. 5. 302-311
Ami Watanabe, Seiji Maruo, Taku Ito, Miho Ito, Koichi Ricardo Katsumura, Kenzo Takada. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. Journal of virology. 2010. 84. 6. 2893-901

MISC (7)：

田中杏奈, 渡邊亜美, 山下泉[菅原], 宮島篤. iPS細胞由来膵β細胞の大量調製に向けた膵前駆細胞の性状解析と増幅法の開発. 日本生化学会大会プログラム・講演要旨集. 2018. 91回. [3P-342]
霜田雅之, 矢部茂治, 篠原孝也, 元文姫, 福田沙月, 渡邊亜美, 渡邊貴一, 篠原満利恵, 井上貴史, 伊吹将人, et al. 再生医療と移植医療の新展開 iPS細胞を用いた次世代型膵島移植療法の開発. 糖尿病. 2016. 59. Suppl.1. S-106
霜田雅之, 矢部茂治, 篠原孝也, 元文姫, 福田沙月, 渡邊亜美, 渡邊貴一, 篠原満利恵, 井上貴史, 伊吹将人, et al. iPS細胞を用いた次世代型膵島移植療法の開発. 糖尿病(Web). 2016. 59. Suppl
渡邊亜美, 宮島篤. 【糖尿病領域における再生医療の現状と展望】多能性幹細胞からの膵島組織作製. 月刊糖尿病. 2015. 7. 3. 16-24
渡邊亜美, 宮島篤. 【再生医療の最新の進歩(前篇) 次世代再生医療に向けた基盤研究】iPS細胞を用いた再生医療への挑戦糖尿病治療を目指したiPS細胞からの膵島形成. 最新医学. 2014. 69. 3月増刊. 630-638

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page